Journal:
:hepatitis monthly
0
seyed younes hosseini department of virology, vaswmu} oodmwe{cuniwg{wow}s, tarbiat modares university, p. o. box: 14115-331, ir iran +98-2182883880, sabahi_f@modares.ac.ir; gastroentero -hepatology research center, shiraz university of medical sciences, ir iran
farzaneh sabahi department of virology, vaswmu} oodmwe{cuniwg{wow}s, tarbiat modares university, p. o. box: 14115-331, ir iran +98-2182883880, sabahi_f@modares.ac.ir; department of virology, vaswmu} oodmwe{cuniwg{wow}s, tarbiat modares university, p. o. box: 14115-331, ir iran +98-2182883880, sabahi_f@modares.ac.ir
seyed mohammad moazzeni department of immunology, tarbiat modares university, ir iran
mohammad hossein modarressi department of medical genetic, tehran university of medical sciences, ir iran
mehdi saberi firoozi digestive disease research center, tehran university of medical sciences, ir iran
mehrdad ravanshad department of virology, vaswmu} oodmwe{cuniwg{wow}s, tarbiat modares university, p. o. box: 14115-331, ir iran +98-2182883880, sabahi_f@modares.ac.ir
background in spite of dozens of clinical trials to establish effective therapeutic and/or preventive vaccine to resolve hcv infection, no real vaccine has been proved to date. genetic vaccines based on replication-defective adenoviruses have proved to elicit strong and long lasting t-cell responses against a number of viral antigens and are even currently being used for vaccine trials in human...